Reference : The combined effect of SR4233 (Tirapazamine®) and FMdC on radiation sensitivity in vitro...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : Oncology
http://hdl.handle.net/2268/122931
The combined effect of SR4233 (Tirapazamine®) and FMdC on radiation sensitivity in vitro and in vivo: is this effect linked to inhibition of angiogenesis?